MusclePharm Releases New Formulation of Award-Winning Pre-Workout Product ASSAULT™

Enhanced Formula First to Contain Revolutionary New Caffeine Ingredient PurEnergy™

PR Newswire
MusclePharm Releases New Formulation of Award-Winning Pre-Workout Product ASSAULT™
.

View photo

MusclePharm Releases New Formulation of ASSAULT(TM) Click Here to Download Image

DENVER, Aug. 1, 2013 /PRNewswire/ -- MusclePharm Corporation (MSLP), a nutritional supplement company focused on active lifestyles, launched today a reformulation of its most popular pre-workout supplement ASSAULT. 

(Photo:  http://photos.prnewswire.com/prnh/20130801/LA57046)

(Logo:  http://photos.prnewswire.com/prnh/20130715/LA46954LOGO)

ASSAULT was named Pre-Workout Product of the Year 2012 by BodyBuilding.com, the Internet's most-visited bodybuilding and fitness site and the largest online retailer of nutritional supplements.  The new improved version of ASSAULT includes a number of new active ingredients providing fitness enthusiasts with the most advanced, safest and effective pre-workout product on the market.

ASSAULT is the first sports nutritional supplements to feature ChromaDex's PurEnergy™, a patented co-crystal ingredient comprised of caffeine and pTeroPure® pterostilbene offering a safer way to get energized.  PurEnergy delivers sustained energy that lasts eight times longer than normal caffeine and doesn't result in the usual caffeine "crash."  PurEnergy also provides health benefits in the areas of cognitive function, antioxidant activity, heart health and weight management. 

The new formula also contains ingredients that increase strength, endurance, muscle mass and energy levels amping up training capacity for longer and harder workouts.  These ingredients include patented CarnoSyn® Beta-Alanine, ION-3 Nitrate Technology nutrients and PurEnergy.

"MusclePharm strives to stay ahead of the industry by continuously researching and developing the most safe and optimal formulations for current and future products to help our customers achieve the most from their fitness regimens," said Brad Pyatt, founder and CEO, MusclePharm.

ABOUT MUSCLEPHARM CORPORATION:
MusclePharm was founded in 2008 by former NFL player Brad Pyatt and just four years later was named "Brand of the Year" by Bodybuilding.com.  MusclePharm develops and manufactures daily supplement regimens to assist consumers and athletes with muscle building, weight loss and general fitness.  All of the products, including the new version of ASSAULT, are developed by leading nutritional scientists via a six-stage research process at the MusclePharm Sports Science Center & Research Center in Denver, Colorado.

MusclePharm is a healthy lifestyle company that develops and manufactures nutritional supplements that address active lifestyles, including muscle building, weight loss and maintaining general fitness through a daily nutritional supplement regimen. MusclePharm's products are sold to consumers in more than 110 countries and available in over 10,500 U.S. retail outlets, including Dick's Sporting Goods, GNC, Vitamin Shoppe and Vitamin World. MusclePharm products also are sold through more than 100 online channels globally, including bodybuilding.com, amazon.com and vitacost.com. For more information, please visit www.musclepharm.com.  You can also follow MusclePharm online at www.facebook.com/MusclePharm and www.twitter.com/MusclePharm.

Forward Looking Statements
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

MusclePharm Contact:
Ivy Mollenkamp/Amy Pandya
Rogers & Cowan
310-854-8131/310-854-8262
imollenkamp@rogersandcowan.com 
apandya@rogersandcowan.com

View Comments